Fox Chase Presents on Disparities in Cancer Prevention and Treatment In November 2014, Evelyn González (far left), senior director of the Fox Chase Office of Health Communications and Health Disparities, presented at the seventh AACR conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. During her presentation, González shared information on why it is important to include different racial and ethnic groups when embarking on new and improved methods of cancer screening, prevention, and treatment.
GI Clinical Trials Make Meeting Headlines Fox Chase was well represented at the annual GI ASCO Symposium in January. Many fellows, residents, and faculty members attended, with nine making poster presentations on topics around esophageal, pancreatic, and colorectal cancers. Medical oncologist Wafik El-Deiry, MD, PhD, FACP, also presented oral abstracts on two anti-angiogenic agents for metastatic colorectal cancer (mCRC) going through Phase II and III trials. His discussion made headline news at the Symposium.
San Antonio Breast Cancer Symposium In January, Fox Chase hosted its 13th Annual Highlights from the San Antonio Breast Cancer Symposium in collaboration with OncLive. Led by Lori J. Goldstein, MD, FASCO, the program included faculty from both Fox Chase Cancer Center and the University of Pennsylvania. More than 170 physicians and nurses attended the program in Philadelphia, which provided relevant updates on the management of breast cancer and premalignant breast disease. The event has come to be regarded by local clinicians as a critical resource for learning about recent research findings and advances in breast cancer care. American Society … Continue Reading »
In order to mature into functional lymphocytes, stem and progenitor cells depend on receptors that pick up subtle changes in the cellular environment and relay that information to the nucleus, which turns the right genes on and off. And that’s where things can get complicated. Continue Reading »
Surgical oncologist Jeffrey Farma, MD, FACS, was invited last fall to Germany as the 2014 American College of Surgeons (ACS) Traveling Fellow. The fellowship provided Farma with a better understanding of German surgical training and education and the country’s national health care system, specifically multidisciplinary cancer care and clinical trial procedures. Farma visited six medical centers and attended the 131st Congress of the German Society for Surgery (GSS) in Berlin, where he presented in the session, “Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.” During the Congress, he also talked about his experience as an ACS scholar and participated … Continue Reading »
The following is an article by Fox Chase medical oncologist Daniel M. Geynisman, MD. The piece, published in the December 15, 2014 issue of the Journal of Clinical Oncology, discusses the pitfalls and positives of being a doctor in the age of e-mail. The next time you are sitting in Grand Rounds, standing in the cafeteria line, rounding with your team, or giving a talk, take a look at your colleagues. Chances are, they are staring at a screen, and many are probably checking e-mail. E-mail has changed how physicians communicate. Whether related to patient care, academic pursuits, or administrative … Continue Reading »
Beginning this year, the American College of Surgeons is requiring the assessment of psychological distress as part of the vital signs process. The College’s actions recognize the powerful impact of mental and behavioral health on patients’ treatment decisions and outcomes. If patients have less distress, they tend to take a more active role in their care and can do better in treatment. Fox Chase Cancer Center is going even beyond the College’s requirements to assess and treat patient distress. The Center’s new standards build on its own success in identifying and meeting patient needs through initiatives such as survivor support … Continue Reading »
Jean-Pierre Issa, MD, co-leader of the cancer epigenetics group and director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine, was honored with the 2014 Scientific Research Award for his important contributions in the field of epigenetics in the pathophysiology and treatment of cancer. Issa has helped reveal that different cancers arise along different molecular routes, and his work has led to promising biomarkers for cancer detection, prognosis, and prediction. His proof-of-principle for epigenetic therapy of cancer is now standard of care in several types of leukemias.